<h1>Exacta AI Revolutionizes Cancer Treatment with Personalized Multi-Drug Options for Hard-to-Treat Cases</h1> Datar Cancer Genetics has introduced Exacta AI, an advanced AI-driven platform designed to provide personalized treatment options for patients with difficult-to-treat cancers. This platform integrates comprehensive tumor analysis with AI-assisted data interpretation to offer up to 10 evidence-based multi-drug treatment combinations. Exacta AI evaluates drug interactions, toxicity, and contraindications, aiding oncologists and molecular tumor boards in making informed decisions. It processes vast datasets rapidly, transforming complex data into actionable insights. In a study, Exacta AI generated significantly more treatment options compared to conventional methods, offering new hope for patients with no standard care options.